Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 safety and tolerability study of BYON5667 eye drops in healthy subjects
NL-OMON50780Phase 1Completed
- Sponsor
- Byondis
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of sodium thiosulfate (2 arms), sponsored by Byondis. Primary endpoint: Incidence of adverse events. Started Mar 2021; status: completed.
02
Drugs
sodium thiosulfate
Beyond the preview
Go deeper on NL-OMON50780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50780.